News

Applied Therapeutics' New Drug Application for a rare metabolic disease was rejected by the Food and Drug Administration, causing its shares to crater Friday.

The coming week will give investors a fresh view into the health of the U.S. economy with the release of a closely watched employment report that could help determine the trajectory of interest rates in the months ahead. Part of that performance has been fueled by expectations that the Federal Reserve will continue cutting interest rates into next year, after reducing borrowing costs by 75 basis points in 2024. But uncertainty over the Fed’s rate trajectory has increased in recent months as a spate of robust economic data - including a blowout jobs report for September - stirs concerns that inflation could rebound if the central bank lowers rates too far, undoing two years of progress in tamping down prices.

What will be open (or closed) after the Thanksgiving holiday? Here’s what to expect.

Nvidia shares have added $2.9 trillion in market value since the launch of ChatGPT in November of 2022.

Risks that sparked equity sell-offs will linger in 2025, says Deutsche Bank

On Wednesday, Grifols SA (NASDAQ:GRFS) said it ended discussions with Brookfield Capital Partners (UK) Limited about a potential acquisition. This decision follows the company’s November 19 statement rejecting Brookfield’s indicative offer to acquire Grifols for 6.45 billion euros ($6.81 billion) or 10.50 euros per Class A share. Canadian fund Brookfield said it had dropped its plan to take over Spain’s Grifols due to a disagreement over the pharmaceutical company’s value, while Grifols said it

(Bloomberg) -- Russia’s rock-bottom unemployment rate should be the envy of any country, but it’s instead underscoring how the labor shortage fueled by the Kremlin’s 2022 invasion of Ukraine is making it more difficult for companies to operate.Most Read from BloombergIn Traffic-Weary Toronto, a Battle Breaks Out Over Bike LanesIn Italy’s Motor City, Car-Free Options Are GrowingNew York City’s ‘Living Breakwaters’ Brace for Stormier SeasThe share of the labor force out of work in Russia, already

The hedge-fund manager frankly addresses what could happen to the stock market next.

ParaZero Technologies Ltd. (NASDAQ:PRZO) shares are rising on Friday following the company’s announcement that it received the Design Verification Report (DVR) approval from the European Union Aviation Safety Agency (EASA). This approval applies to ParaZero’s SafeAir M-300 Pro and SafeAir M-350 Pro parachute safety kits, confirming compliance with critical safety standards. The EASA DVR allows drone operators to expand their operational scope under the Specific Operations Risk Assessment (SORA)

News of the day for Nov. 29, 2024